user avatar
Abbott Cardiovascular
Abbott
@AbbottCardio
We’re leading the way in heart and vascular health. Committed to #cardiovascular care. Proud member of #CardioTwitter. ToU: abbo.tt/2FxLOXN
Abbott Park, IL
Joined April 2013
Posts
  • user avatar
    Reach for #XIENCE because your stent choice lives with them. XIENCE is the drug eluting #stent that consistently delivers successful outcomes – not only in the cath lab but far beyond. #ReachForXIENCE bit.ly/3hXZkr0 Important Safety Info: bit.ly/33QjLRK
    00:00
  • user avatar
    What makes #XIENCE unique? - Innovative Stent Design - Anti-Thrombotic Fluoropolymer - Market Leading Everolimus See how #XIENCE is uniquely designed for exceptional clinical performance: bit.ly/2ScXqIt Important Safety Info: bit.ly/3igMSCR
  • user avatar
    Where have you seen technology improve #PatientCare the most? #CardioTwitter
  • user avatar
    10 years ago, the FDA approved the first #XIENCE stent for #heartdisease. We’re marking a legacy of innovation by hosting a LIVE video from our R&D lab in #SiliconValley. Mark your calendars and join us! #CardioTwitter #medtech Important Safety Info: abbo.tt/2t7d2QM
  • user avatar
    Welcome to #EuroPCR! We’re excited for this year because we have a lot to share between our booth talks and training sessions. ❤️ Come by our booth F12: abbo.tt/2ZWIEIt
  • user avatar
    Who else is excited for #EuroPCR? 🤓 This year we’re sharing an interactive program with multiple educational training sessions. Check out the schedule and register today! abbo.tt/2Jq1f9U
  • user avatar
    #EuroPCR attendees: ⏰ it’s the last day to pre-register for training sessions! Be sure to sign-up today to secure your spot. abbo.tt/2LmcKls
  • user avatar
    Join Abbott engineers next Weds for a LIVE video from our #SiliconValley R&D lab! We’ll talk evolution and #innovation since FDA approval of the first-generation #XIENCE drug-eluting stent 10 years ago! #medtech #CardioTwitter Important Safety Info: abbo.tt/2LMj3Kv
  • user avatar
    Life-changing technology isn’t one product, it’s a solution for better patient outcomes. Deploying #XIENCE using new #OCTimaging AptiVue Software means precise #DES placement, expansion and apposition. Important Safety Info: bit.ly/2NeSNu4 bit.ly/2VIph7r
  • user avatar
    JUST RELEASED at #PCReCourse: 1/LightLab Decision Making Data show #OCTimaging changed angiographic-based decisions in 88% of lesions. Read more: AbbottOCT.com #imagefirst #imagelast Important Safety Info: bit.ly/2VIph7r
  • user avatar
    BREAKING 📰: The world’s first-and-only contact force catheter with a flexible tip is now approved for use in the US. Discover our #TactiFlex #Ablation Catheter, SE: abbott.mediaroom.com/2023-05-19-Abb… Safety Info: cardiovascular.abbott/us/en/hcp/prod…
  • user avatar
    Breaking – #TactiFlex PAF IDE study will enroll 355 patients to evaluate the TactiFlex™ Ablation Catheter, Sensor Enabled™ (TactiFlex SE) to treat recurrent #AFib. ➡bit.ly/31hMNbx Caution: TactiFlex SE is an investigational device. Not available for sale in the U.S.
  • user avatar
    .@DrChuckSimonton knows that not all diets are #HeartHealthy. How do you talk to patients about diet during #HeartHealthMonth?
    GIF
  • user avatar
    1/Welcome to our first OCT #Tweetorial! We'll cover a few key concepts and share a step-by-step guide on the basics of image interpretation 🤓 #imagefirst #OCTimaging Important Safety Info: abbo.tt/2GyBrZ1